Medicare Certification and CHOW
Certification, provider enrollment, state licensure, CHOW timing, and transfer requirements can affect process and closing risk.
Medicare-certified home health M&A
To sell a home health agency, start with a private readiness check, not a listing: confirm your Medicare enrollment history (including where you stand on the 36-month rule), license and survey status, payer mix, referral concentration, and clinical leadership, then take a confidential valuation. Home Care Business Broker is a home health business broker that runs that process for Medicare-certified and skilled agency owners.
Home Care Business Broker helps home health agency owners understand value, prepare for diligence, protect confidentiality, and run a controlled process without exposing staff, referral sources, patients, or local competitors too early.
Home health agencies are valued based on normalized earnings, payer mix, clinical census, skilled nursing and therapy mix, referral sources, survey history, compliance posture, staff retention, owner dependence, and buyer fit. Medicare certification and CHOW planning make the sale process different from non-medical home care.
Home health diligence
Home health buyers are not only reviewing revenue. They are testing whether clinical operations, certifications, referral relationships, payer economics, and transition requirements can survive a sale.
Certification, provider enrollment, state licensure, CHOW timing, and transfer requirements can affect process and closing risk.
Buyers review census, admissions, discharges, episode quality, nursing mix, therapy mix, acuity, and referral stability.
Survey history, plans of correction, documentation practices, billing controls, audits, and open issues can become major diligence topics.
Medicare rules
The 36-month rule. If your agency is within 36 months of its initial Medicare enrollment or its last change in majority ownership, a majority ownership change generally forces the buyer to enroll as a new provider and pass a new initial survey or accreditation before billing Medicare. Limited exceptions exist. Buyers check this date first, and so should you.
Change of ownership (CHOW). Medicare requires notice of a change of ownership, filed through the CMS-855A enrollment application. In an asset purchase, the buyer can usually accept assignment of your Medicare provider agreement, taking on its history, including any overpayment liabilities, or decline it and enroll fresh, which means a gap before it can bill Medicare. Deal structure follows from that choice. Our Medicare CHOW guide covers the steps in detail.
Certificate of need. In states that require a certificate of need for home health, that license can be a large part of what a buyer pays for.
Payment and quality. Medicare pays home health under the Patient-Driven Groupings Model. Since 2025, Medicare's nationwide Home Health Value-Based Purchasing Model has adjusted payments up or down based on quality scores. Buyers look at star ratings, the share of patients on Medicare Advantage plans (which often pay less than traditional Medicare), and how margins have tracked recent rate changes.
Valuation drivers
Buyers evaluate earnings, but they also test whether the agency can maintain referral flow, staff continuity, clinical operations, and compliance after closing.
| Driver | What Buyers Review | Why It Affects Value |
|---|---|---|
| Normalized earnings | SDE or EBITDA, add-backs, owner compensation, non-recurring costs, margins, and working capital needs. | Creates the financial basis for valuation and deal structure. |
| Payer mix | Medicare, Medicare Advantage, Medicaid, commercial, VA, private pay, and concentration. | Payer mix affects margin quality, authorization burden, and buyer appetite. |
| Clinical census quality | Admissions, discharges, census trend, care mix, episode quality, recertifications, and referral durability. | Shows whether revenue is stable and transferable. |
| Staff and leadership | RN leadership, clinical managers, therapists, aides, turnover, recruiting, and management depth. | Clinical continuity supports buyer confidence and patient care transition. |
| Compliance posture | Survey history, plans of correction, billing documentation, audits, and open issues. | Compliance uncertainty can reduce price or slow diligence. |
| Owner dependence | Owner role in referrals, operations, clinical oversight, billing, and key relationships. | Heavy owner involvement can reduce perceived transferability. |
Sale process
A controlled process helps the owner understand value, prepare clinical and financial diligence, screen buyers, and plan for licensure and transition requirements before sensitive information is shared.
| Stage | What Happens | Home Health Focus |
|---|---|---|
| Valuation and readiness | Review financials, payer mix, census, clinical staff, referral sources, survey history, compliance, and owner role. | Identify CHOW, certification, survey, payer, and staffing risks before buyer outreach. |
| Sale preparation | Organize buyer materials, diligence support, confidentiality controls, and process strategy. | Prepare clinical, financial, licensure, and compliance materials before disclosure. |
| Confidential outreach | Approach selected buyers under a staged disclosure process. | Protect staff, patients, referral partners, local reputation, and competitor-sensitive information. |
| Buyer screening | Review buyer capital, home health experience, licensure fit, operating ability, and confidentiality risk. | Make sure buyer fit is strong before sensitive clinical and referral details are released. |
| Offer, diligence, and transition | Support LOI review, diligence, CHOW/licensure planning, negotiation, close, and owner handoff. | Manage certification, survey, clinical continuity, and referral handoff through closing. |
Timeline
Preparation often takes weeks to a few months: financial cleanup, a risk inventory, and a Medicare and licensing review. Confidential marketing to first offers commonly takes a few months more. From letter of intent to close, allow several additional months for quality-of-earnings review, CHOW filings, state licensing, and payer notices. Change-of-ownership and licensing steps alone can stretch closing, so build in margin. If you face a fixed personal deadline, say so early; it changes how the process is designed.
Buyer diligence
Home health buyers want to know whether the agency can maintain clinical operations, referral sources, payer economics, and compliance after the owner transitions out.
Provider enrollment, Medicare certification, state licensure, CHOW requirements, transfer timing, and buyer eligibility.
P&Ls, add-backs, owner compensation, payroll, non-recurring costs, payer revenue, and margin trend.
Census trend, admissions, discharges, care mix, episode quality, referral concentration, and acuity.
Clinical leadership, RN and therapist roster, turnover, recruiting, scheduler depth, and management structure.
Survey outcomes, plans of correction, billing files, audit history, documentation quality, and open issues.
Hospitals, physicians, discharge planners, facilities, community sources, and relationship transferability.
Buyer landscape
Most buyers fall into three groups: private equity-backed home health and hospice platforms adding locations, regional operators expanding their footprint or adding skilled services to a non-medical base, and hospital or health-system-affiliated organizations building post-acute capacity. Each weighs licensure, payer mix, and census differently, so the buyer list shapes both price and structure.
Confidentiality
A home health sale can disrupt clinical staff, patients, families, referral partners, and local reputation if information is released too early. Buyer screening and staged disclosure matter.
Nurses, therapists, aides, clinical managers, and office staff need careful communication timing.
Patient continuity and family trust should be protected until a transition plan is ready.
Hospitals, physicians, discharge planners, facilities, and community partners should not hear sale rumors early.
Buyers should be screened for capital, licensure fit, home health experience, and confidentiality before receiving detail.
Preparation checklist
You can start with a confidential valuation before every item is complete, but these materials help clarify value and reduce diligence friction.
Recent P&Ls, tax returns, payroll, owner compensation, payer revenue, non-recurring costs, and margin trend.
Census trend, admissions, discharges, care mix, recertifications, referral sources, and episode quality.
Medicare certification, provider enrollment, state license, survey results, plans of correction, and transfer requirements.
Clinical leadership, RN roster, therapist roster, aides, turnover, recruiting, management depth, and open roles.
Billing documentation, audit history, compliance policies, HIPAA practices, quality controls, and open issues.
Owner role, staff communication, patient continuity, referral handoff, CHOW timing, and post-close support.
Specialist advisor
A generalist business broker can run a process, but home health sales turn on Medicare enrollment history, survey results, payer mix, and referral concentration. A home health business broker surfaces those issues before buyers do, targets buyers who already underwrite skilled home health, and structures the deal around CHOW timing so you aren't negotiating against a buyer who does this every quarter.
Related resources
Use these paths based on where you are in the decision process. If you are still deciding, start with value, readiness, and buyer fit before broader outreach.
See how the confidential sell-side process works for home care, home health, hospice, and senior care owners.
Start with a confidential valuation to understand likely value, readiness, buyer fit, and diligence risks before selling.
Review change-of-ownership context before a buyer process creates transfer and timing questions.
Learn how the temporary CMS home health and hospice enrollment moratorium may affect agency sales, CHOW/CIMO review, buyer diligence, and timing.
Review 2026 healthcare and home care valuation multiples, buyer diligence factors, earnings quality, payer mix, and sale preparation issues.
Home health seller questions
Yes. A controlled process can protect clinical staff, patients, families, referral sources, and competitors by screening buyers before sensitive information is released.
Value starts with normalized earnings (SDE or EBITDA), then adjusts for payer mix, census trend, star ratings, referral diversity, clinical leadership, whether you hold a certificate of need, and where you stand on the 36-month rule. Smaller agencies are often valued differently from larger platforms. A grounded range comes after those facts are reviewed. Request a confidential valuation.
Home health often involves Medicare certification, skilled clinical care, CHOW or licensure planning, survey history, clinical documentation, and payer complexity that non-medical private duty agencies may not have.
Buyers review financials, payer mix, census trend, referral sources, staff retention, clinical leadership, survey history, compliance posture, CHOW requirements, and transition risk.
Yes. Change-of-ownership and licensure requirements can affect diligence, timing, buyer qualification, and closing structure, so they should be reviewed early.
Yes. Many owners start with a confidential valuation to understand value, readiness, buyer fit, and preparation steps before deciding whether to go to market.
Potential buyers include strategic home health operators, home care and hospice continuum buyers, regional healthcare groups, and healthcare-services platforms.
Private next step
If you own a Medicare-certified or skilled home health agency, start with a private conversation about value, buyer fit, timing, diligence readiness, and how to protect staff, patients, referral sources, and licenses during a sale.